BIOMAT Database Logo BIOMAT Database Logo

Clinical significance of serum beta 2-microglobulin in leukemia. 1982

T Kageyama, and H Oyabu, and S Tsumoto

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009365 Neoplasm Regression, Spontaneous Disappearance of a neoplasm or neoplastic state without the intervention of therapy. Neoplasm Remission, Spontaneous,Remission, Spontaneous Neoplasm,Regression, Spontaneous Neoplasm,Spontaneous Neoplasm Regression,Spontaneous Neoplasm Remission
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Kageyama, and H Oyabu, and S Tsumoto
Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia.
April 1995, Leukemia,
T Kageyama, and H Oyabu, and S Tsumoto
[Clinical significance of serum and university beta 2--microglobulin (author's transl)].
September 1977, Radioisotopes,
T Kageyama, and H Oyabu, and S Tsumoto
[Clinical significance of the radioimmunoassay of serum beta 2-microglobulin in diabetics].
April 1985, Zhonghua yi xue za zhi,
T Kageyama, and H Oyabu, and S Tsumoto
[Serum beta 2 microglobulin in chronic lymphoid leukemia].
July 1985, Orvosi hetilap,
T Kageyama, and H Oyabu, and S Tsumoto
Clinical significance of beta 2 microglobulin determination.
January 1980, Acta clinica Belgica,
T Kageyama, and H Oyabu, and S Tsumoto
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.
December 1992, The American journal of medicine,
T Kageyama, and H Oyabu, and S Tsumoto
Serum beta 2-microglobulin in adult acute lymphocytic leukemia.
April 1994, The American journal of medicine,
T Kageyama, and H Oyabu, and S Tsumoto
[Serum beta-2 microglobulin in chronic lymphatic leukemia in relation to clinical staging].
January 1982, Sangre,
T Kageyama, and H Oyabu, and S Tsumoto
[Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
May 1989, Zhonghua nei ke za zhi,
T Kageyama, and H Oyabu, and S Tsumoto
[Clinical significance of beta-2-microglobulin in diabetes mellitus].
January 1989, Orvosi hetilap,
Copied contents to your clipboard!